Stay updated on Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.
Latest updates to the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedThe Locations section now includes recruitment sites in New Jersey and New York, with the locations updated accordingly. The HHS Vulnerability Disclosure footer link has been removed and previous location subsections were replaced in the new version.SummaryDifference0.3%
- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedPublication notes were updated to state that publications are automatically filled in from PubMed and may not all be about the study. The page revision label was updated to v3.3.2; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check57 days agoChange DetectedRemoved the government funding operating status notice from the page; the study details, locations, and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check78 days agoChange DetectedNo additions or deletions were detected on the page; the content remains focused on the study details for NCT02684253.SummaryDifference0.4%
- Check100 days agoChange DetectedSignificant update: adds a government-status notice and a v3.2.0 version tag, removing the old v3.1.0 tag.SummaryDifference3%
- Check107 days agoChange DetectedUpdated version to v3.1.0 and removed the specific resource for head and neck squamous cell carcinoma; overall, this is a version update with a targeted resource removal.SummaryDifference0.5%
Stay in the know with updates to Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.